Discover 332 paid clinical trials in New Mexico. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
New Mexico provides a wide selection of paid research opportunities for both healthy volunteers and individuals with specific health conditions. Leading research sites in Albuquerque, Santa Fe, and Las Cruces are actively recruiting, offering early access to innovative treatments and exceptional healthcare.
Filter
1
Filter results
Results: 332
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 30
Code: NCT03126916
Phase 3, Recruiting
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Long Island City NY, Danbury CT, Great Neck NY,
Sponsor: Apellis Pharmaceuticals, Inc.
Sex: All
Age: 60+
Code: NCT07215390
Phase 2, Recruiting
Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
for
Uterine Cancer, Endometrial Cancer
Location: St Louis MO, Albuquerque NM
Sponsor: Washington University School of Medicine
Sex: Female
Age: 18+
Code: NCT06795009
Phase 1, Recruiting
Mindfulness Texting for Medication Adherence and Chronic Pain Management
for
Opioid Use Disorder (OUD), Chronic Pain
Location: Albuquerque NM
Sponsor: University of New Mexico
Sex: All
Age: 18+
Code: NCT07711795
Recruiting
Continued Pressure for Alveolar Protection (CPAP Trial)
for
Bronchopulmonary Dysplasia (BPD)
Location: Philadelphia PA, Durham NC, Cleveland OH, Atlanta GA,
Sponsor: NICHD Neonatal Research Network
Sex: All
Age: 0
Code: NCT07417111
Recruiting
Education & Mentorship of Advanced Practice Providers to Increase Community-based Research Within the NCORP Network, COACH-APP Trial
for
Other
Location: Augusta ME, Brunswick ME, Portland ME, Scarborough ME,
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18+
Code: NCT06904391
Recruiting
A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
for
Severe Alopecia Areata
Location: Hershey PA, Washington D.C. DC, Miami FL, Charleston SC,
Sponsor: Pfizer
Sex: All
Age: 6 - 14
Code: NCT07029828
Phase 3, Recruiting
Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial
for
Endometrial Endometrioid Adenocarcinoma,
Location: Iowa City IA, Albuquerque NM
Sponsor: New Mexico Cancer Research Alliance
Sex: Female
Age: 18+
Code: NCT07436793
Phase 2, Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
for
Asthma
Location: Hawthorne NY, The Bronx NY, Ocean City NJ, New York NY,
Sponsor: AstraZeneca
Sex: All
Age: 12 - 17
Code: NCT06307665
Phase 3, Recruiting
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
Location: Scarborough ME, The Bronx NY, Albany NY,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT07022678
Phase 3, Recruiting
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
for
Colon Adenocarcinoma, Rectal Adenocarcinoma
Location: Moncton, Chicoutimi, New York NY, Hackensack NJ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06997497
Phase 3, Recruiting
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
for
Melanoma (Skin Cancer), Melanoma Stage IIIB-IV,
Location: Boston MA, Philadelphia PA, Tampa FL, Aurora CO,
Sponsor: Linnaeus Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06624644
Phase 2, Phase 3, Recruiting
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
for
Core Binding Factor Acute Myeloid Leukemia
Location: Boston MA, Providence RI, The Bronx NY, Wilkes-Barre PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT06917911
Phase 2, Recruiting
Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients